Financhill
Back

AGF US Market Neutral Anti-Beta Fund Vs. Moderna Industry Stock Comparison

Sell
46

BTAL
AGF US Market Neutral Anti-Beta Fund

Last Price:
$18.15
Seasonality Move:
0.51%
Sell
30

MRNA
Moderna

Last Price:
$43.18
Seasonality Move:
19.59%
Sell
46
AGF US Market Neutral Anti-Beta Fund (BTAL) is a Sell

Is AGF US Market Neutral Anti-Beta Fund a Buy, Sell or Hold?

  • The current AGF US Market Neutral Anti-Beta Fund [BTAL] share price is $18.17. The Score for BTAL is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • BTAL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Moderna (MRNA) is a Sell

Is Moderna a Buy, Sell or Hold?

  • The current Moderna [MRNA] share price is $43.17. The Score for MRNA is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • MRNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BTAL Stock Price Chart

What is AGF US Market Neutral Anti-Beta Fund's stock price today?

  • The AGF US Market Neutral Anti-Beta Fund share price today is $18.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAL is experiencing slight selling pressure.

MRNA Stock Price Chart

What is Moderna's stock price today?

  • The Moderna share price today is $43.17
    The current trend is relatively stagnant and MRNA is experiencing selling pressure, which indicates risk of future bearish movement.

BTAL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 39.58 Sell
Chaikin Money Flow: -107181 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.3 - 18.92) Sell
Bollinger Bands (100): (18.81 - 20.11) Sell

MRNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 51.57 Buy
Chaikin Money Flow: -12329110 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.77 - 43.83) Buy
Bollinger Bands (100): (41.23 - 71.05) Sell

BTAL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.38 Sell
20-day SMA: 18.62 Sell
50-day SMA: 18.97 Sell
200-day SMA: 19.31 Sell
8-day EMA: 18.33 Sell
20-day EMA: 18.56 Sell
50-day EMA: 18.9 Sell
200-day EMA: 19.26 Sell

MRNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.32 Buy
20-day SMA: 41.39 Buy
50-day SMA: 43.78 Sell
200-day SMA: 88.05 Sell
8-day EMA: 42.86 Buy
20-day EMA: 42.19 Buy
50-day EMA: 46.17 Sell
200-day EMA: 75 Sell

AGF US Market Neutral Anti-Beta Fund Earnings Growth & BTAL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Moderna Earnings Growth & MRNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $2.01 per share.

AGF US Market Neutral Anti-Beta Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Moderna Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):